Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection

Int J Dermatol. 2017 Feb;56(2):218-220. doi: 10.1111/ijd.13337. Epub 2016 Jun 23.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use*
  • Behcet Syndrome / complications
  • Behcet Syndrome / drug therapy*
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / adverse effects
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use*
  • Male
  • Time Factors
  • Tuberculosis / complications*
  • Uveitis / drug therapy
  • Uveitis / etiology

Substances

  • Antirheumatic Agents
  • Interleukin 1 Receptor Antagonist Protein